Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction
International Journal of Cardiology · 2023
DOI: 10.1016/j.ijcard.2023.02.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cardiology, 2023. Verfasst von Masami Nishino und 24 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, Japan. Electronic address: mnishino@osakah.johas.go…. Hauptthemen laut MEDLINE: Heart Failure, Atrial Fibrillation, Coronary Artery Disease, Frailty. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Herzinsuffizienz, Medikationssicherheit
Abstract (Originalsprache)
BACKGROUNDS: Drug treatments of heart failure with preserved ejection fraction (HFpEF) have a little clinical benefit, but cardiovascular polypharmacy (CP) trend is observed in elderly HFpEF. We investigated the impact of CP on octogenarian with HFpEF. METHODS: We examined 783 consecutive octogenarians (≥80 years) enrolled in the PURSUIT-HFpEF registry. We defined medications for hypertension, dyslipidemia, heart failure (HF), coronary artery disease, stroke, peripheral artery disease, and atrial fibrillation as cardiovascular medications (CM). In this study, we defined CP as ≥5 CM. We investigated whether CP was correlated with the composite end point (CE) of all-cause mortality and HF rehospitalization. RESULTS: The proportion with CP was 51.9% (n = 406). Background characteristics correlated with CP were frailty, history of coronary artery disease, atrial fibrillation and left atrial dimension. Multivariable Cox proportional hazards analysis showed CP was significantly and independently correlated with CE (hazard ratio (HR): 1.31; 95% confidence Interval (CI): 1.01-1.70) in addition to age, clinical frailty scale, history of HF admission and N-terminal pro brain natriuretic peptide. Kaplan-Meier curve analysis showed that, compared with the non-CP group, the CP group had significantly higher risk of CE and HF (HR: 1.27; 95%CI: 1.04-1.56; P = 0.02 and HR: 1.46; 95%CI: 1.13-1.88; P < 0.01, respectively), but not any-cause death. In addition, diuretics were correlated with CE (HR: 1.61; 95%CI: 1.17-2.22; P < 0.01), but antithrombotic drugs and HFpEF medications were not. CONCLUSIONS: CP at discharge is a prognostic factor driven by HF rehospitalization in octogenarians with HFpEF. In these patients, diuretics may be correlated with the prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, Japan. Electronic address: mnishino@osakah.johas.go.jp.
- Division of Cardiology, Osaka Rosai Hospital, 3-1179 Nagasonecho, Kita-ku, Sakai, Osaka 591-8025, Japan.
- Division of Cardiology, Osaka General Medical Center, 3-1-56 Mandaihigashi, Sumiyoshi-ku, Osaka 558-8558, Japan.
- Division of Cardiology, Amagasaki Chuo Hospital, 1-12-1 Shioe, Amagasaki, Hyogo 661-0976, Japan.
- Division of Cardiology, Rinku General Medical Center, 2-23 Rinkuoraikita, Izumisano, Osaka 598-0048, Japan.
- Cardiovascular Division, Osaka Police Hospital, 10-31 Kitayamacho, Tennoji-ku, Osaka 543-0035, Japan.
Zitieren
APA
Nishino, M., Egami, Y., Kawanami, S., Sugae, H., Ukita, K., Kawamura, A., Nakamura, H., Yasumoto, K., Tsuda, M., Okamoto, N., Matsunaga-Lee, Y., Yano, M., Tanouchi, J., Yamada, T., Yasumura, Y., Seo, M., Tamaki, S., Hayashi, T., Nakagawa, A., …, & Osaka CardioVascular Conference (OCVC)-Heart Failure Investigators (2023). Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction. International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2023.02.021
Vancouver
Nishino M, Egami Y, Kawanami S, Sugae H, Ukita K, Kawamura A, et al. Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction. International Journal of Cardiology. 2023. doi:10.1016/j.ijcard.2023.02.021
BibTeX
@article{Nishino2023,
author = {Nishino, Masami and Egami, Yasuyuki and Kawanami, Shodai and Sugae, Hiroki and Ukita, Kohei and Kawamura, Akito and Nakamura, Hitoshi and Yasumoto, Koji and Tsuda, Masaki and Okamoto, Naotaka and Matsunaga-Lee, Yasuharu and Yano, Masamichi and Tanouchi, Jun and Yamada, Takahisa and Yasumura, Yoshio and Seo, Masahiro and Tamaki, Shunsuke and Hayashi, Takaharu and Nakagawa, Akito and Nakagawa, Yusuke and Sotomi, Yohei and Nakatani, Daisaku and Hikoso, Shungo and Sakata, Yasushi and Osaka CardioVascular Conference (OCVC)-Heart Failure Investigators, Osaka CardioVascular Conference (OCVC)-Heart Failure Investigators},
title = {Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction},
journal = {International Journal of Cardiology},
year = {2023},
doi = {10.1016/j.ijcard.2023.02.021}
}
EUVIMED